Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (231-240 of 453) with videos related to

Pageof 46
Sort By:
Acta Neuropathologica|September 11, 2024
HOXD12 defines an age-related aggressive subtype of oligodendrogliomaNicholas Nuechterlein, Sadie Cimino, Allison Shelbourn, et al.
Journal of Neurosurgery|November 4, 2008
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trialEdward G Shaw, Brian Berkey, Stephen W Coons, et al.
Molecular Oncology|December 2, 2021
Cysteine is a limiting factor for glioma proliferation and survivalVictor Ruiz-Rodado, Tyrone Dowdy, Adrian Lita, et al.
Journal of Neuro-Oncology|April 28, 2006
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant statusMorris D Groves, Vinay K Puduvalli, Charles A Conrad, et al.
CNS Oncology|February 10, 2022
Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology BranchOrwa Aboud, Ritu Shah, Elizabeth Vera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802Edward G Shaw, Meihua Wang, Stephen W Coons, et al.
BMC Cancer|March 2, 2018
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four casesSurabhi Ranjan, Martha Quezado, Nancy Garren, et al.
Cancers|May 17, 2019
A Transgenic Mouse Model of Pacak⁻Zhuang Syndrome with An <i>Epas1</i> Gain-of-Function MutationHerui Wang, Jing Cui, Chunzhang Yang, et al.
Comprehensive Psychoneuroendocrinology|June 27, 2022
Associations of meaning of illness with psychosocial, clinical, and immunological characteristics in patients with Leptomeningeal metastasisJulie G Walker, Terri S Armstrong, Barbara J O'Brien, et al.
Scientific Reports|June 19, 2024
PLX038A, a long-acting SN-38, penetrates the blood-tumor-brain-barrier, accumulates and releases SN-38 in brain tumors to increase survival of tumor bearing miceJinkyu Jung, Eric L Schneider, Wei Zhang, et al.
Pageof 46

Showing results (231-240 of 453) with videos related to

Sort By:
Pageof 46
Acta Neuropathologica|September 11, 2024
HOXD12 defines an age-related aggressive subtype of oligodendrogliomaNicholas Nuechterlein, Sadie Cimino, Allison Shelbourn, et al.
Journal of Neurosurgery|November 4, 2008
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trialEdward G Shaw, Brian Berkey, Stephen W Coons, et al.
Molecular Oncology|December 2, 2021
Cysteine is a limiting factor for glioma proliferation and survivalVictor Ruiz-Rodado, Tyrone Dowdy, Adrian Lita, et al.
Journal of Neuro-Oncology|April 28, 2006
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant statusMorris D Groves, Vinay K Puduvalli, Charles A Conrad, et al.
CNS Oncology|February 10, 2022
Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology BranchOrwa Aboud, Ritu Shah, Elizabeth Vera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802Edward G Shaw, Meihua Wang, Stephen W Coons, et al.
BMC Cancer|March 2, 2018
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four casesSurabhi Ranjan, Martha Quezado, Nancy Garren, et al.
Cancers|May 17, 2019
A Transgenic Mouse Model of Pacak⁻Zhuang Syndrome with An <i>Epas1</i> Gain-of-Function MutationHerui Wang, Jing Cui, Chunzhang Yang, et al.
Comprehensive Psychoneuroendocrinology|June 27, 2022
Associations of meaning of illness with psychosocial, clinical, and immunological characteristics in patients with Leptomeningeal metastasisJulie G Walker, Terri S Armstrong, Barbara J O'Brien, et al.
Scientific Reports|June 19, 2024
PLX038A, a long-acting SN-38, penetrates the blood-tumor-brain-barrier, accumulates and releases SN-38 in brain tumors to increase survival of tumor bearing miceJinkyu Jung, Eric L Schneider, Wei Zhang, et al.
Pageof 46